Evidence map›Paper›PMID 32499533›Full record

ArticleCell death & disease2020

Hexokinase 2 is dispensable for photoreceptor development but is required for survival during aging and outer retinal stress.

Eric Weh, Zuzanna Lutrzykowska, Andrew Smith, Heather Hager, Mercy Pawar, Thomas J Wubben, Cagri G Besirli

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A pathway to sight.eLife · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Eric WehDepartment of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall St., Ann Arbor, MI, 48105, US.
Zuzanna LutrzykowskaUniversity of Michigan, Ann Arbor, MI, US.
Andrew SmithDepartment of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall St., Ann Arbor, MI, 48105, US.
Heather HagerDepartment of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall St., Ann Arbor, MI, 48105, US.
Mercy PawarDepartment of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall St., Ann Arbor, MI, 48105, US.
Thomas J WubbenDepartment of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall St., Ann Arbor, MI, 48105, US.
Cagri G BesirliDepartment of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall St., Ann Arbor, MI, 48105, US. cbesirli@med.umich.edu.ORCID http://orcid.org/0000-0001-7154-2024
University of Michigan · US

Funding

VIVARIUM MODULEP30EY007003 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti · 1987 to 2026
$17.6M
Metabolic Reprogramming for Photoreceptor NeuroprotectionR01EY029675 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BESIRLI, CAGRI · 2019 to 2023
$2.1M
Neuroprotection in pediatric retinal detachmentK08EY023982 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BESIRLI, CAGRI · 2014 to 2018
$925k
NEI NIH HHS K08 EY023982NEI NIH HHS P30 EY007003NEI NIH HHS R01 EY029675
6 · The paper itself

Abstract

Photoreceptor death is the ultimate cause of vision loss in many retinal degenerative conditions. Identifying novel therapeutic avenues for prolonging photoreceptor health and function has the potential to improve vision and quality of life for patients suffering from degenerative retinal disorders. Photoreceptors are metabolically unique among other neurons in that they process the majority of their glucose via aerobic glycolysis. One of the main regulators of aerobic glycolysis is hexokinase 2 (HK2). Beyond its enzymatic function of phosphorylating glucose to glucose-6-phosphate, HK2 has additional non-enzymatic roles, including the regulation of apoptotic signaling via AKT signaling. Determining the role of HK2 in photoreceptor homeostasis may identify novel signaling pathways that can be targeted with neuroprotective agents to boost photoreceptor survival during metabolic stress. Here we show that following experimental retinal detachment, p-AKT is upregulated and HK2 translocates to mitochondria. Inhibition of AKT phosphorylation in 661W photoreceptor-like cells results in translocation of mitochondrial HK2 to the cytoplasm, increased caspase activity, and decreased cell viability. Rod-photoreceptors lacking HK2 upregulate HK1 and appear to develop normally. Interestingly, we found that HK2-deficient photoreceptors are more susceptible to acute nutrient deprivation in the experimental retinal detachment model. Additionally, HK2 appears to be important for preserving photoreceptors during aging. We show that retinal glucose metabolism is largely unchanged after HK2 deletion, suggesting that the non-enzymatic role of HK2 is important for maintaining photoreceptor health. These results suggest that HK2 expression is critical for preserving photoreceptors during acute nutrient stress and aging. More specifically, p-AKT mediated translocation of HK2 to the mitochondrial surface may be critical for protecting photoreceptors from acute and chronic stress.

Indexed as

Stress, PhysiologicalAgingAnimalsCaspasesCell SurvivalChromonesCytosolEnzyme ActivationGene Knockdown TechniquesHexokinaseMice, Inbred C57BLMice, KnockoutMitochondriaModels, BiologicalMorpholinesProtein Transport2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneCaspasesChromonesHexokinasehexokinase 2, mouseMorpholines

Identifiers

PMID32499533
PMCPMC7272456
OpenAlexW3033657812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.